{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:03:47Z","timestamp":1780013027088,"version":"3.53.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shenzhen Longhua District Science and Technology Innovation Fund","award":["SZLHQJCYJ2021001"],"award-info":[{"award-number":["SZLHQJCYJ2021001"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82104457"],"award-info":[{"award-number":["82104457"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47805-y","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T05:48:35Z","timestamp":1775713715000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AC decoction augments chemotherapy in NSCLC by reshaping the tumor immune microenvironment: attenuating Tregs and enhancing CD8+ T cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Wei","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-ye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo-zhen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-yong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-chao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-hui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-wang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"47805_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"47805_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"47805_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.7888\/juoeh.40.173","volume":"40","author":"K Yoneda","year":"2018","unstructured":"Yoneda, K., Imanishi, N., Ichiki, Y. & Tanaka, F. Immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC). J. UOEH 40, 173\u2013189. https:\/\/doi.org\/10.7888\/juoeh.40.173 (2018).","journal-title":"J. UOEH"},{"key":"47805_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-024-02596-z","volume":"19","author":"A Elicora","year":"2024","unstructured":"Elicora, A. et al. Prognostic significance of t lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy. J. Cardiothorac. Surg. 19, 113. https:\/\/doi.org\/10.1186\/s13019-024-02596-z (2024).","journal-title":"J. Cardiothorac. Surg."},{"key":"47805_CR5","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1091\/mbc.E14-04-0916","volume":"25","author":"BA Weaver","year":"2014","unstructured":"Weaver, B. A. How taxol\/paclitaxel kills cancer cells. Mol. Biol. Cell 25, 2677\u20132681. https:\/\/doi.org\/10.1091\/mbc.E14-04-0916 (2014).","journal-title":"Mol. Biol. Cell"},{"key":"47805_CR6","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","volume":"379","author":"SJ Antonia","year":"2018","unstructured":"Antonia, S. J. et al. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. N. Engl. J. Med. 379, 2342\u20132350. https:\/\/doi.org\/10.1056\/NEJMoa1809697 (2018).","journal-title":"N. Engl. J. Med."},{"key":"47805_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020683","volume":"99","author":"X Sui","year":"2020","unstructured":"Sui, X. et al. Combination of traditional Chinese medicine and epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of non-small cell lung cancer: A systematic review and meta-analysis. Med. (Baltimore) 99, e20683. https:\/\/doi.org\/10.1097\/MD.0000000000020683 (2020).","journal-title":"Med. (Baltimore)"},{"key":"47805_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111381","volume":"137","author":"Z Li","year":"2021","unstructured":"Li, Z., Feiyue, Z. & Gaofeng, L. Traditional Chinese medicine and lung cancer\u2014\u2014from theory to practice. Biomed. Pharmacother. 137, 111381. https:\/\/doi.org\/10.1016\/j.biopha.2021.111381 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"47805_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1142\/S0192415X16500014","volume":"44","author":"KK Auyeung","year":"2016","unstructured":"Auyeung, K. K., Han, Q.-B. & Ko, J. K. Astragalus membranaceus: A review of its protection against inflammation and gastrointestinal cancers. Am. J. Chin. Med. 44, 1\u201322. https:\/\/doi.org\/10.1142\/S0192415X16500014 (2016).","journal-title":"Am. J. Chin. Med."},{"key":"47805_CR10","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S466633","volume":"16","author":"Z Li","year":"2024","unstructured":"Li, Z. et al. Astragalus membranaceus: A review of its antitumor effects on non-small cell lung cancer. Cancer Manag. Res. 16, 909. https:\/\/doi.org\/10.2147\/CMAR.S466633 (2024).","journal-title":"Cancer Manag. Res."},{"key":"47805_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/srep44822","volume":"7","author":"L Zhou","year":"2017","unstructured":"Zhou, L. et al. Astragalus polysaccharides exerts immunomodulatory effects via TLR4-mediated MyD88-dependent signaling pathway in vitro and in vivo. Sci. Rep. 7, 44822. https:\/\/doi.org\/10.1038\/srep44822 (2017).","journal-title":"Sci. Rep."},{"key":"47805_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9206951","volume":"2019","author":"T-H Wu","year":"2019","unstructured":"Wu, T.-H. et al. The combination of Astragalus membranaceus and Angelica sinensis inhibits lung cancer and cachexia through its immunomodulatory function. J. Oncol. 2019, 9206951. https:\/\/doi.org\/10.1155\/2019\/9206951 (2019).","journal-title":"J. Oncol."},{"key":"47805_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.117863","volume":"261","author":"F Luan","year":"2021","unstructured":"Luan, F. et al. Extraction, purification, structural characteristics and biological properties of the polysaccharides from Codonopsis pilosula: A review. Carbohydr. Polym. 261, 117863. https:\/\/doi.org\/10.1016\/j.carbpol.2021.117863 (2021).","journal-title":"Carbohydr. Polym."},{"key":"47805_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25214895","volume":"25","author":"A Atiq","year":"2020","unstructured":"Atiq, A. & Parhar, I. Anti-neoplastic potential of flavonoids and polysaccharide phytochemicals in glioblastoma. Molecules 25, 4895. https:\/\/doi.org\/10.3390\/molecules25214895 (2020).","journal-title":"Molecules"},{"key":"47805_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185254","author":"X R","year":"2017","unstructured":"R, X., L, L. & Y, L. ShenQi FuZheng injection combined with chemotherapy in the treatment of colorectal cancer: A meta-analysis. PLoS One https:\/\/doi.org\/10.1371\/journal.pone.0185254 (2017).","journal-title":"PLoS One"},{"key":"47805_CR16","doi-asserted-by":"publisher","DOI":"10.2147\/BCTT.S475860","volume":"16","author":"Y Ma","year":"2024","unstructured":"Ma, Y., Bai, B., Liu, D., Shi, R. & Zhou, Q. Shenqi fuzheng injection reduces Cisplatin-induced kidney injury via cGAS\/STING signaling pathway in breast cancer mice model. Breast Cancer: Targets Ther. 16, 451. https:\/\/doi.org\/10.2147\/BCTT.S475860 (2024).","journal-title":"Breast Cancer: Targets Ther."},{"key":"47805_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12950-015-0108-x","volume":"12","author":"J Jackute","year":"2015","unstructured":"Jackute, J. et al. The prognostic influence of tumor infiltrating Foxp3\u2009+\u2009CD4+, CD4\u2009+\u2009and CD8\u2009+\u2009T cells in resected non-small cell lung cancer. J. Inflamm. 12, 63. https:\/\/doi.org\/10.1186\/s12950-015-0108-x (2015).","journal-title":"J. Inflamm."},{"key":"47805_CR18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.0105-2896.2010.00899.x","volume":"235","author":"R Arens","year":"2010","unstructured":"Arens, R. & Schoenberger, S. P. Plasticity in programming of effector and memory CD8+ t\u2010cell formation. Immunol. Rev. 235, 190. https:\/\/doi.org\/10.1111\/j.0105-2896.2010.00899.x (2010).","journal-title":"Immunol. Rev."},{"key":"47805_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2009.06.018","volume":"16","author":"DG DeNardo","year":"2009","unstructured":"DeNardo, D. G. et al. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16, 91\u2013102. https:\/\/doi.org\/10.1016\/j.ccr.2009.06.018 (2009).","journal-title":"Cancer Cell"},{"key":"47805_CR20","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.21037\/jtd-19-3414a","volume":"12","author":"AB Schulze","year":"2020","unstructured":"Schulze, A. B. et al. Tumor infiltrating T cells influence prognosis in stage I-III non-small cell lung cancer. J. Thorac. Dis. 12, 1824\u20131842. https:\/\/doi.org\/10.21037\/jtd-19-3414a (2020).","journal-title":"J. Thorac. Dis."},{"key":"47805_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1089\/cbr.2018.2672","volume":"34","author":"X Hu","year":"2019","unstructured":"Hu, X., Gu, Y., Zhao, S., Hua, S. & Jiang, Y. Elevated circulating CD4\u2009+\u2009CD25-Foxp3\u2009+\u2009regulatory T cells in patients with nonsmall cell lung cancer. Cancer Biother. Radiopharm. 34, 325\u2013333. https:\/\/doi.org\/10.1089\/cbr.2018.2672 (2019).","journal-title":"Cancer Biother. Radiopharm."},{"key":"47805_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-3-030-49270-0_6","volume":"1273","author":"RE Dadey","year":"2020","unstructured":"Dadey, R. E., Workman, C. J. & Vignali, D. A. A. Regulatory T cells in the tumor microenvironment. Adv. Exp. Med. Biol. 1273, 105\u2013134. https:\/\/doi.org\/10.1007\/978-3-030-49270-0_6 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"47805_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2020.07.022","volume":"490","author":"R Saleh","year":"2020","unstructured":"Saleh, R. & Elkord, E. FoxP3\u2009+\u2009T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets. Cancer Lett. 490, 174\u2013185. https:\/\/doi.org\/10.1016\/j.canlet.2020.07.022 (2020).","journal-title":"Cancer Lett."},{"key":"47805_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03136","volume":"10","author":"A Colamatteo","year":"2019","unstructured":"Colamatteo, A. et al. Molecular mechanisms controlling Foxp3 expression in health and autoimmunity: From epigenetic to post-translational regulation. Front. Immunol. 10, 3136. https:\/\/doi.org\/10.3389\/fimmu.2019.03136 (2019).","journal-title":"Front. Immunol."},{"key":"47805_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nri.2015.18","volume":"16","author":"M DuPage","year":"2016","unstructured":"DuPage, M. & Bluestone, J. A. Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease. Nat. Rev. Immunol. 16, 149\u2013163. https:\/\/doi.org\/10.1038\/nri.2015.18 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"47805_CR26","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1074\/jbc.M116.749663","volume":"292","author":"OF Sarmento","year":"2017","unstructured":"Sarmento, O. F. et al. The role of the histone methyltransferase enhancer of zeste homolog 2 (EZH2) in the pathobiological mechanisms underlying inflammatory bowel disease (IBD). J. Biol. Chem. 292, 706\u2013722. https:\/\/doi.org\/10.1074\/jbc.M116.749663 (2017).","journal-title":"J. Biol. Chem."},{"issue":"2","key":"47805_CR27","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.18632\/oncotarget.2834","volume":"6","author":"M Scheffler","year":"2015","unstructured":"Scheffler, M. et al. PIK3CA mutations in non-small cell lung cancer (NSCLC): Genetic heterogeneity, prognostic impact and incidence of prior malignancies.. Oncotarget 6(2), 1315. https:\/\/doi.org\/10.18632\/oncotarget.2834 (2015).","journal-title":"Oncotarget"},{"key":"47805_CR28","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/1759-7714.13328","volume":"11","author":"AC Tan","year":"2020","unstructured":"Tan, A. C. Targeting the PI3K\/Akt\/mTOR pathway in non-small cell lung cancer (NSCLC).. Thorac. Cancer 11, 511. https:\/\/doi.org\/10.1111\/1759-7714.13328 (2020).","journal-title":"Thorac. Cancer"},{"key":"47805_CR29","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.trecan.2022.06.008","volume":"8","author":"F Shan","year":"2022","unstructured":"Shan, F., Somasundaram, A., Bruno, T. C., Workman, C. J. & Vignali, D. A. A. Therapeutic targeting of regulatory T cells in cancer.. Trends Cancer 8, 944. https:\/\/doi.org\/10.1016\/j.trecan.2022.06.008 (2022).","journal-title":"Trends Cancer"},{"key":"47805_CR30","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1002\/fsn3.1154","volume":"7","author":"X-Q Zhang","year":"2019","unstructured":"Zhang, X.-Q. et al. Effects of Astragaloside IV on treatment of breast cancer cells execute possibly through regulation of Nrf2 via PI3K\/AKT\/mTOR signaling pathway.. Food Sci. Nutr. 7, 3403\u20133413. https:\/\/doi.org\/10.1002\/fsn3.1154 (2019).","journal-title":"Food Sci. Nutr."},{"key":"47805_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/biom15030380","volume":"15","author":"I Imtiaz","year":"2025","unstructured":"Imtiaz, I., Schloss, J. & Bugarcic, A. Interplay between traditional and scientific knowledge: Phytoconstituents and their roles in lung and colorectal cancer signaling pathways.. Biomolecules 15, 380. https:\/\/doi.org\/10.3390\/biom15030380 (2025).","journal-title":"Biomolecules"},{"issue":"9","key":"47805_CR32","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1158\/2326-6066.CIR-16-0365","volume":"5","author":"HY Li","year":"2017","unstructured":"Li, H. Y. et al. The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1\/PD-L1 Antibody Blockade. Cancer Immunol. Res. 5 (9), 767\u2013777. https:\/\/doi.org\/10.1158\/2326-6066.CIR-16-0365 (2017).","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"47805_CR33","doi-asserted-by":"publisher","first-page":"e20210815","DOI":"10.1084\/jem.20210815","volume":"219","author":"D Kerdidani","year":"2022","unstructured":"Kerdidani, D. et al. Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts. J. Exp. Med. 219 (2), e20210815. https:\/\/doi.org\/10.1084\/jem.20210815 (2022).","journal-title":"J. Exp. Med."},{"key":"47805_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157330","volume":"148","author":"B Bai","year":"2025","unstructured":"Bai, B. et al. Astragaloside IV potentiates cisplatin sensitivity in triple-negative breast cancer via STING signaling pathway activation.. Phytomedicine 148, 157330. https:\/\/doi.org\/10.1016\/j.phymed.2025.157330 (2025).","journal-title":"Phytomedicine"},{"key":"47805_CR35","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1089\/acm.2015.0214","volume":"22","author":"W-R Tang","year":"2016","unstructured":"Tang, W.-R. et al. Long-term effectiveness of combined treatment with traditional Chinese medicine and Western medicine on the prognosis of patients with lung cancer. J. Altern. Complement. Med. 22, 212\u2013222. https:\/\/doi.org\/10.1089\/acm.2015.0214 (2016).","journal-title":"J. Altern. Complement. Med."},{"key":"47805_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119802","volume":"348","author":"L Kewang","year":"2025","unstructured":"Kewang, L., Wei, Y., Meiye, L., Tianyong, H. & Baohui, C. The inhibitory effects of modified HSJZ decoction on NSCLC by regulating regulatory T cells via downregulation of EZH2 and PI3K\/AKT pathway. J. Ethnopharmacol. 119802. https:\/\/doi.org\/10.1016\/j.jep.2025.119802 (2025).","journal-title":"J. Ethnopharmacol."},{"key":"47805_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijbiomac.2022.01.140","volume":"203","author":"N Hu","year":"2022","unstructured":"Hu, N. et al. Uniform and disperse selenium nanoparticles stabilized by inulin fructans from Codonopsis Pilosula and their anti-hepatoma activities. Int. J. Biol. Macromol. 203, 105\u2013115. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.01.140 (2022).","journal-title":"Int. J. Biol. Macromol."},{"key":"47805_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-021-00564-6","volume":"17","author":"Y Bian","year":"2022","unstructured":"Bian, Y. et al. Astragalus membranaceus (Huangqi) and Rhizoma curcumae (Ezhu) decoction suppresses colorectal cancer via downregulation of Wnt5\/\u03b2-catenin signal. Chin. Med. 17, 11. https:\/\/doi.org\/10.1186\/s13020-021-00564-6 (2022).","journal-title":"Chin. Med."},{"key":"47805_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","volume":"22","author":"M Philip","year":"2022","unstructured":"Philip, M. & Schietinger, A. CD8\u2009+\u2009T cell differentiation and dysfunction in cancer. Nat. Rev. Immunol. 22, 209\u2013223. https:\/\/doi.org\/10.1038\/s41577-021-00574-3 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"47805_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-025-04823-z","volume":"25","author":"B He","year":"2025","unstructured":"He, B., Cui, J., Zhang, Z. & Zhang, Y. Combining network pharmacology and molecular docking to explore the pharmacological mechanism of Codonopsis Radix.-Hedysarum Multijugum Maxim.-Atractylodes Macrocephala Koidz. in treating lung cancer. BMC Complement. Med. Ther. 25, 66. https:\/\/doi.org\/10.1186\/s12906-025-04823-z (2025).","journal-title":"BMC Complement. Med. Ther."},{"key":"47805_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.143739","volume":"311","author":"R Chen","year":"2025","unstructured":"Chen, R. et al. Astragalus polysaccharides inhibits tumor proliferation and enhances cisplatin sensitivity in bladder cancer by regulating the PI3K\/AKT\/FoxO1 axis. Int. J. Biol. Macromol. 311, 143739. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.143739 (2025).","journal-title":"Int. J. Biol. Macromol."},{"key":"47805_CR42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.canlet.2021.10.010","volume":"524","author":"F Chen","year":"2022","unstructured":"Chen, F. et al. EZH2 inhibition confers PIK3CA-driven lung tumors enhanced sensitivity to PI3K inhibition. Cancer Lett. 524, 151. https:\/\/doi.org\/10.1016\/j.canlet.2021.10.010 (2022).","journal-title":"Cancer Lett."},{"issue":"2","key":"47805_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.canlet.2015.01.031","volume":"359","author":"J Geng","year":"2015","unstructured":"Geng, J. et al. EZH2\u2002promotes tumor progression via;regulating VEGF-A\/AKT signaling in\u2002non-small\u2002cell\u2002lung\u2002cancer. Cancer Lett. 359(2), 275\u201387. https:\/\/doi.org\/10.1016\/j.canlet.2015.01.031 (2015).","journal-title":"Cancer Lett."},{"key":"47805_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.155992","volume":"270","author":"K Mortezaee","year":"2025","unstructured":"Mortezaee, K. EZH2\u2002regulatory\u2002roles in cancer\u2002immunity\u2002and immunotherapy. Pathol. Res. Pract. 270, 155992 (2025).","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"47805_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ccell.2024.11.006","volume":"43","author":"Y Isshiki","year":"2025","unstructured":"Isshiki, Y. et al. EZH2\u2002inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function. Cancer Cell. 43(1), 49-68e9 (2025).","journal-title":"Cancer Cell."},{"key":"47805_CR46","doi-asserted-by":"publisher","first-page":"15598","DOI":"10.3390\/ijms242115598","volume":"24","author":"Y Fan","year":"2023","unstructured":"Fan, Y. et al. Systemic immunomodulatory effects of Codonopsis pilosula glucofructan on S180 solid-tumor-bearing mice. Int. J. Mol. Sci. 24, 15598. https:\/\/doi.org\/10.3390\/ijms242115598 (2023).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47805-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47805-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47805-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T23:48:45Z","timestamp":1780012125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47805-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47805"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47805-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16691"}}